Literature DB >> 19635844

Exon-trapping mediated by the human retrotransposon SVA.

Dustin C Hancks1, Adam D Ewing, Jesse E Chen, Katsushi Tokunaga, Haig H Kazazian.   

Abstract

Although most human retrotransposons are inactive, both inactive and active retrotransposons drive genome evolution and may influence transcription through various mechanisms. In humans, three retrotransposon families are still active, but one of these, SVA, remains mysterious. Here we report the identification of a new subfamily of SVA, which apparently formed after an alternative splicing event where the first exon of the MAST2 gene spliced into an intronic SVA and subsequently retrotransposed. Additional examples of SVA retrotransposing upstream exons due to splicing into SVA were also identified in other primate genomes. After molecular and computational experiments, we found a number of functional 3' splice sites within many different transcribed SVAs across the human and chimpanzee genomes. Using a minigene splicing construct containing an SVA, we observed splicing in cell culture, along with SVA exonization events that introduced premature termination codons (PTCs). These data imply that an SVA residing within an intron in the same orientation as the gene may alter normal gene transcription either by gene-trapping or by introducing PTCs through exonization, possibly creating differences within and across species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635844      PMCID: PMC2775590          DOI: 10.1101/gr.093153.109

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  45 in total

1.  Exon shuffling by L1 retrotransposition.

Authors:  J V Moran; R J DeBerardinis; H H Kazazian
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

2.  Identification, characterization, and cell specificity of a human LINE-1 promoter.

Authors:  G D Swergold
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 3.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.

Authors:  E Nagy; L E Maquat
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

4.  Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions.

Authors:  J Rohrer; Y Minegishi; D Richter; J Eguiguren; M E Conley
Journal:  Clin Immunol       Date:  1999-01       Impact factor: 3.969

Review 5.  Mechanism and regulation of mRNA polyadenylation.

Authors:  D F Colgan; J L Manley
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

6.  LINEs and Alus--the polyA connection.

Authors:  J D Boeke
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

7.  dbEST--database for "expressed sequence tags".

Authors:  M S Boguski; T M Lowe; C M Tolstoshev
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

8.  A novel mobile element inserted in the alpha spectrin gene: spectrin dayton. A truncated alpha spectrin associated with hereditary elliptocytosis.

Authors:  H Hassoun; T L Coetzer; J N Vassiliadis; K E Sahr; G J Maalouf; S T Saad; L Catanzariti; J Palek
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

9.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy.

Authors:  K Kobayashi; Y Nakahori; M Miyake; K Matsumura; E Kondo-Iida; Y Nomura; M Segawa; M Yoshioka; K Saito; M Osawa; K Hamano; Y Sakakihara; I Nonaka; Y Nakagome; I Kanazawa; Y Nakamura; K Tokunaga; T Toda
Journal:  Nature       Date:  1998-07-23       Impact factor: 49.962

10.  Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication.

Authors:  L Shen; L C Wu; S Sanlioglu; R Chen; A R Mendoza; A W Dangel; M C Carroll; W B Zipf; C Y Yu
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  58 in total

1.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

Review 2.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

3.  Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution.

Authors:  Shai Carmi; George M Church; Erez Y Levanon
Journal:  Nat Commun       Date:  2011-11-01       Impact factor: 14.919

4.  Muscular dystrophy: A hidden ancestral legacy trumped.

Authors:  Masayuki Nakamori; Charles Thornton
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

5.  5'-Transducing SVA retrotransposon groups spread efficiently throughout the human genome.

Authors:  Annette Damert; Julija Raiz; Axel V Horn; Johannes Löwer; Hui Wang; Jinchuan Xing; Mark A Batzer; Roswitha Löwer; Gerald G Schumann
Journal:  Genome Res       Date:  2009-08-03       Impact factor: 9.043

Review 6.  Physiology of the read-write genome.

Authors:  James A Shapiro
Journal:  J Physiol       Date:  2014-06-01       Impact factor: 5.182

7.  Composite non-LTR retrotransposons in hominoid primates.

Authors:  Annette Damert
Journal:  Mob Genet Elements       Date:  2015-07-24

8.  Next-generation VariationHunter: combinatorial algorithms for transposon insertion discovery.

Authors:  Fereydoun Hormozdiari; Iman Hajirasouliha; Phuong Dao; Faraz Hach; Deniz Yorukoglu; Can Alkan; Evan E Eichler; S Cenk Sahinalp
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

Review 9.  The impact of retrotransposons on human genome evolution.

Authors:  Richard Cordaux; Mark A Batzer
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

10.  Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer.

Authors:  Simon N Stacey; Birte Kehr; Julius Gudmundsson; Florian Zink; Aslaug Jonasdottir; Sigurjon A Gudjonsson; Asgeir Sigurdsson; Bjarni V Halldorsson; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Katja K H Aben; Sita H Vermeulen; Ruben G Cremers; Angeles Panadero; Brian T Helfand; Phillip R Cooper; Jenny L Donovan; Freddie C Hamdy; Viorel Jinga; Ichiro Okamoto; Jon G Jonasson; Laufey Tryggvadottir; Hrefna Johannsdottir; Anna M Kristinsdottir; Gisli Masson; Olafur T Magnusson; Paul D Iordache; Agnar Helgason; Hannes Helgason; Patrick Sulem; Daniel F Gudbjartsson; Augustine Kong; Eirikur Jonsson; Rosa B Barkardottir; Gudmundur V Einarsson; Thorunn Rafnar; Unnur Thorsteinsdottir; Ioan N Mates; David E Neal; William J Catalona; José I Mayordomo; Lambertus A Kiemeney; Gudmar Thorleifsson; Kari Stefansson
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.